Power Law company profile

Arcutis

Biotech & Life Sciences · Westlake Village, United States · Founded 2016 · IPO 2020 Thoroughbred

Focuses on medical dermatology, leveraging innovations in inflammation and immunology

Valuation

$2.80B

Market cap · May/2026

Revenue

$310M

Latest reported FY

EBITDA

$85M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

4 investors on Arcutis's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Frazier Healthcare Partners

Series B+ 3 investors entered at this stage

OrbiMed

HBM Healthcare Investments

Vivo Capital

Global footprint

Where Arcutis has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States94.2%

🇨🇦 Canada5.8%

2 countries shown

Web traffic by country

28K monthly visits
across markets

🇺🇸 United States50%

🇨🇦 Canada29.3%

🇬🇧 United Kingdom7.5%

🇮🇳 India6.4%

🇦🇺 Australia3.2%

Top 5 markets shown

Market sentiment

What the market is saying about Arcutis

An AI-synthesized read of the highest-engagement posts about Arcutis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arcutis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles